Enrolling By Invitation NA INTERVENTIONAL 2-arm
NCT06906653
Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
Population Health Management for Kaiser Permanente Northern California (KPNC) Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
Sponsor: Kaiser Permanente
Interventions
Augmented Initial Type 2 Diabetes Care
Updated 1 time since 2025 Last updated: Apr 1, 2025 Started: Apr 30, 2025 Primary completion: Dec 31, 2026 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06906653, this NA trial focuses on Type 2 Diabetes and Type 2 Diabetes (T2D) and remains ongoing. Sponsored by Kaiser Permanente, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Enrolling By Invitation — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Kaiser Permanente
- The Permanente Medical Group
Data source: Kaiser Permanente
For direct contact, visit the study record on ClinicalTrials.gov .